Maarten Slagter

Company: CureVacSE

Job title: Scientist Computational Cancer Genomics

Seminars:

Unearthing the Dark Antigenome & Leveraging Machine Learning to Accurately Prioritize Neoantigens 9:05 am

High throughput sequencing technologies are allowing for an ever-increasing resolution of tumour genome characterization, offering exciting windows of opportunity for (personalized) cancer vaccines. How should we identify the most promising targets, with the highest probability of (T cell) immunogenicity? Are there new targets in the genome that were previously left not considered? What roles can…Read more

day: Pre-Conference Day